DEMENTIA MODERATE
Clinical trials for DEMENTIA MODERATE explained in plain language.
Never miss a new study
Get alerted when new DEMENTIA MODERATE trials appear
Sign up with your email to follow new studies for DEMENTIA MODERATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could flickering lights and tones help fight Alzheimer's? major trial underway
Disease control OngoingThis study tests a device that delivers specific light and sound patterns to the brain, aiming to slow the progression of mild-to-moderate Alzheimer's disease. About 670 participants will use the device at home for an hour daily over a year, with half receiving a sham (inactive) …
Matched conditions: DEMENTIA MODERATE
Phase: NA • Sponsor: Cognito Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New pill xanamem aims to slow Alzheimer's decline
Disease control OngoingThis study tests whether a daily 10 mg pill called Xanamem can safely slow memory and function loss in people with mild or moderate Alzheimer's dementia. About 247 participants will receive either Xanamem or a placebo for 36 weeks, with an option to continue the drug for up to 10…
Matched conditions: DEMENTIA MODERATE
Phase: PHASE2, PHASE3 • Sponsor: Actinogen Medical • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC